The Latest Oncology Treatment & Support News
A type of drug known as a PARP inhibitor, already used to treat breast and…
Nevan Krogan, University of California, San Francisco Most antivirals in use today target parts of…
A research team led by the University of Kent and Goethe-University Frankfurt am Main, Germany,…
The characterisation of COVID-19 in patients with cancer remains limited in published studies and nationwide…
Cancers are often heavily reliant on breaking down fats for their growth and spread, and…
A new tool will help researchers and clinicians to classify ovarian cancer patients’ tumours into…
A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve…
Researchers at Children’s Cancer Institute Australia have discovered what could prove a new and improved…
New research indicates that taking vitamin D supplements may help prevent a potentially serious side…
Jonathan C. M. Wan, University of Cambridge; Katrin Heider, University of Cambridge, and Nitzan Rosenfeld,…